CAS 25541-09-7

lacto-N-fucopentaose III* do leite humano

Descrição:

Lacto-N-fucopentaose III (LNFP III) é um oligosacarídeo complexo encontrado predominantemente no leite humano. É classificado como um oligosacarídeo de leite humano (HMO) fucosilado e desempenha um papel significativo na nutrição e desenvolvimento infantil. LNFP III é composto por uma estrutura central de lactose com resíduos adicionais de fucose e N-acetilglucosamina, contribuindo para suas propriedades únicas. Este oligosacarídeo é conhecido por seus efeitos prebióticos, promovendo o crescimento de bactérias intestinais benéficas, o que pode melhorar o sistema imunológico do bebê e a saúde intestinal geral. Além disso, foi demonstrado que o LNFP III inibe a adesão de patógenos ao epitélio intestinal, proporcionando assim um efeito protetor contra infecções. Sua presença no leite humano varia entre indivíduos e pode ser influenciada pela genética materna e fatores dietéticos. O número CAS 25541-09-7 identifica especificamente este composto, facilitando seu estudo em vários contextos de pesquisa científica e nutricional. No geral, o LNFP III exemplifica a complexidade e a importância funcional dos HMOs na lactação humana.

Fórmula: C₃₂H₅₅NO₂₅

InChI: InChI=1/C32H55NO25/c1-8-16(42)20(46)22(48)30(51-8)57-27-15(33-9(2)39)29(54-14(7-38)26(27)56-31-23(49)21(47)18(44)12(5-36)52-31)58-28-19(45)13(6-37)53-32(24(28)50)55-25(11(41)4-35)17(43)10(40)3-34/h3,8,10-32,35-38,40-50H,4-7H2,1-2H3,(H,33,39)

Chave InChI: InChIKey=WMYQZGAEYLPOSX-QKPOUJQKSA-N

SMILES: O([C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](O[C@@H]([C@@H]([C@H](C=O)O)O)[C@@H](CO)O)O[C@H](CO)[C@@H]3O)[C@@H]1NC(C)=O)[C@H]4[C@@H](O)[C@H](O)[C@H](O)[C@H](C)O4

Sinónimos:

• 6-Deoxyhexopyranosyl-(1->3)-[Hexopyranosyl-(1->4)]-2-(Acetylamino)-2-Deoxyhexopyranosyl-(1->3)Hexopyranosyl-(1->4)Hexose
• <span class="text-smallcaps">D</smallcap>-Glucose, O-6-deoxy-α-<smallcap>L</smallcap>-galactopyranosyl-(1→3)-O-[β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-<smallcap>D</smallcap>-glucopyranosyl-(1→3)-O-β-<smallcap>D</span>-galactopyranosyl-(1→4)-
• Glucopyranose, O-6-deoxy-α-<span class="text-smallcaps">L</smallcap>-galactopyranosyl-(1→3)-O-[β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)]-O-2-acetamido-2-deoxy-β-<smallcap>D</smallcap>-glucopyranosyl-(1→3)-O-β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)-, <smallcap>D</span>-
• Lacto-N-fucopentaose III
• Lacto-N-fucopentaose III, Human Milk
• Lacto-N-fucopentoase-3
• Lacto-N-neofucopentaose II
• Le^x penta
• Lnf Iii
• Lnfp Iii
• O-6-Deoxy-α-<span class="text-smallcaps">L</smallcap>-galactopyranosyl-(1→3)-O-[β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-<smallcap>D</smallcap>-glucopyranosyl-(1→3)-O-β-<smallcap>D</smallcap>-galactopyranosyl-(1→4)-<smallcap>D</span>-glucose
• Glucopyranose, O-6-deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-, D-
• O-6-Deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose
• D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-
• LACTO-N-FUCOPENTAOSE III-GEL
• BETA-D-GAL-[1->4]-(ALPHA-L-FUC-[1->3])-BETA-D-GLCNAC-[1->3]-BETA-D-GAL-[1->4]-D-GLC
• III3FUC-NLCOSE4
• LNF III-GEL
• LEWIS-X-PENTASACCHARIDE-GEL
• GAL-BETA1,4(FUC-ALPHA1,3)GLCNAC-BETA1,3GAL-BETA1,4GLC
• β-d-gal-(1→4)-[α-l-fuc-(1→3)]-β-d-glcnac-(1→3)-β-d-gal-(1→4)-d-glc
• CD15 ANTIGEN
• N-[2-[3,5-dihydroxy-2-(hydroxymethyl)-6-(1,2,4,5-tetrahydroxy-6-oxohexan-3-yl)oxyoxan-4-yl]oxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl]acetamide
• Lacto-N-fucopentaose III ,95%
• LEX-PENTASACCHARIDE
• LEWIS-X PENTASACCHARIDE
• LEX
• Lex-lactose, Lewis-X pentasaccharide, LNFP III, β-D-Gal-(1-4)-[α-L-Fuc-(1-3)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc
• LE(X)-LACTOSE

O-6-Deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose

CAS: 25541-09-7

Fórmula: C₃₂H₅₅NO₂₅

Pureza: ≥95%

Cor e Forma: Solid

Peso molecular: 853.7708

Ref: IN-DA007MS9

Lacto-N-fucopentaose III

CAS: 25541-09-7

Fórmula: C₃₂H₅₅NO₂₅

Pureza: ≥ 95%

Cor e Forma: White to almost white lyophilised powder

Peso molecular: 853.77

Ref: 7W-GC2450

Lacto-N-fucopentaose III

CAS: 25541-09-7

Neutral pentasaccharide naturally present in human breast milk

Fórmula: C₃₂H₅₅NO₂₅

Pureza: Min. 95%

Cor e Forma: White Powder

Peso molecular: 853.77 g/mol

Ref: 3D-OL04212

Lacto-N-fucopentaose III-GEL

CAS: 25541-09-7

Lacto-N-fucopentaose III-GEL is a synthetic monosaccharide that is used as a building block for the synthesis of complex carbohydrates. Lacto-N-fucopentaose III-GEL is synthesized from fructose, which is methylated with chloromethylated N,N'-diacetylchitobiose as the methylating agent and sodium methoxide as the catalyst. The resulting glycoconjugate is then treated with hydrofluoric acid to introduce fluorine atoms into the carbohydrate backbone.

Pureza: Min. 95%

Ref: 3D-OL05682